New York, NY, United States of America

Ping-Ying Pan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping-Ying Pan. Retrieved from https://idiyas.com/inventor/ping-ying-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ping-Ying Pan: Innovator in Antibody Research

Introduction

Ping-Ying Pan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of antibody research, particularly in the development of antibodies that target LILRB3. His work has implications for various therapeutic applications.

Latest Patents

Ping-Ying Pan holds a patent for "Anti-LILRB3 antibodies and methods of use thereof." This patent discloses antibodies and antibody fragments that specifically bind to LILRB3. Additionally, it provides compositions comprising these antibodies and methods for their use.

Career Highlights

He is currently affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to advance his research in immunology and antibody development. His work is crucial in understanding the role of LILRB3 in various diseases.

Collaborations

Ping-Ying Pan collaborates with fellow researcher Shu-Hsia Chen, contributing to the advancement of knowledge in their field.

Conclusion

Ping-Ying Pan's innovative work in antibody research exemplifies the importance of scientific inquiry in developing new therapeutic strategies. His contributions are paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…